scientifyRESEARCH
research funding database

This opportunity is currently closed.

Sign up for Content alerts to stay informed when this or related funding opportunities are posted.

RESEARCH FUNDING

Computational Models of Influenza Immunity (U01 Clinical Trial Not Allowed)

Share

Text on a blue background says "Want to find funding & get support for grant-writing?" Logos of scientifyRESEARCH & GrantDesk appear below on a white background and an orange plus symbol appears between the two logos.
Text on a blue background says "Want to find funding & get support for grant-writing?" Logos of scientifyRESEARCH & GrantDesk appear below on a white background and an orange play symbol appears between the two logos. An arrow mark points to the logos.

The Computational Models of Influenza Immunity (U01 Clinical Trial Not Allowed) funding program from the National Institutes of Health (NIH) supports researchers worldwide working on Computational Models of Influenza Immunity (CMII). The program will employ computational modeling and immunologic studies to advance our understanding of the requirements for improving anti-influenza immunity, including inducing broad immune protection and enhancing immune durability. Projects may lead to a better understanding of how pre-existing immunity and repeat exposures (natural infection and/or vaccines) shape an individual’s immune “landscape.” Applications are open to researchers in the USA and worldwide. Applicants may apply for up to 750,000 USD/year for up to 5 years.

Opportunity ID: RFA-AI-23-026.

Letters of intent are due December 26, 2023. Full applications are due January 26, 2024.

Full application due:
January 26, 2024

non member

More related info for you

Register for free

Don´t have an account?

Start with our free trial to enjoy our 7 days of unlimited grant access and our premium features.

or, Choose a plan to subscribe to our premium membership.

Be the first to know

Sign-up for Personalized Grant alerts

Logo3

Sign-up for our
monthly research
funding newsletter

You can unsubscribe at any time.